Cancer-ID is a Dutch research program with the goal to develop new technology for monitoring cancer therapy through extracellular vesicle (EV) identification. In the program, 10 research groups and 23 companies collaborate. The program runs from 2015 to 2020.
A part of this program is to improve the sensitivity and specificity of EV measurements by modifying the hardware of an existing flow cytometer. The task of Exometry is to model the light scattering signal of the modified flow cytometer to determine the size and refractive index of individual particles. Based on the particle refractive index, EV may be distinguished from other particles in plasma without the need of fluorescent antibody labeling.